Literature DB >> 11870363

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Jordi Bruix1, Josep M Llovet.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11870363     DOI： 10.1053/jhep.2002.32089

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  298 in total

1.  Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.

Authors:  Celia Pamela Corona-Villalobos; Vivek Gowdra Halappa; Susanne Bonekamp; John Eng; Diane Reyes; David Cosgrove; Neda Rastegar; Li Pan; Timothy M Pawlik; Ihab R Kamel
Journal:  Invest Radiol       Date:  2015-04       Impact factor: 6.016

Review 2.  Treatment strategies for hepatocellular carcinoma in cirrhosis.

Authors:  W Scott Helton; Adrian Di Bisceglie; Ravi Chari; Myron Schwartz; Jordi Bruix
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

Review 3.  Hepatocellular carcinoma: epidemic and treatment.

Authors:  Jill Allen; Alan Venook
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

4.  Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.

Authors:  Zhi-Jie Niu; Yi-Long Ma; Ping Kang; Sheng-Qiu Ou; Zhi-Bin Meng; Zhi-Kun Li; Feng Qi; Chang Zhao
Journal:  Med Oncol       Date:  2011-12-27       Impact factor: 3.064

5.  Paraparesis caused by transarterial chemoembolization: A case report.

Authors:  Kashif Tufail; Victor Araya; Ashaur Azhar; David Hertzog; Kamran Khanmoradi; Jorge Ortiz
Journal:  World J Hepatol       Date:  2010-07-27

6.  Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.

Authors:  Young-Joo Jin; Young-Hwa Chung; Jeong A Kim; Won Hyung Park; Danbi Lee; Dong Dae Seo; Soo Hyung Ryu; Myoung Kuk Jang; Eunsil Yu; Young Joo Lee
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

7.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

8.  Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Authors:  Xin-Sen Xu; Kai Qu; Chang Liu; Yue-Lang Zhang; Jun Liu; Yan-Zhou Song; Peng Zhang; Si-Nan Liu; Hu-Lin Chang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 9.  Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.

Authors:  Hwi Young Kim; Joong-Won Park
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

10.  Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Authors:  J Qi; J Wang; H Katayama; S Sen; S M Liu
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.